Cite
HARVARD Citation
Brandt, W. et al. (2022). Efficacy and safety of apixaban for primary prevention of thromboembolism in patients with cancer and a central venous catheter: A subgroup analysis of the AVERT Trial. Thrombosis research. pp. 8-10. [Online].